Intermittent intravenous ibandronate injections reduce vertebral fracture risk in corticosteroid-induced osteoporosis: results from a long-term comparative study.
about
Bisphosphonates: mechanism of action and role in clinical practiceManagement of glucocorticoid-induced osteoporosis: clinical data in relation to disease demographics, bone mineral density and fracture risk.Calcaneal BMD Obtained by Dual X-Ray and Laser Predicts Future Hip Fractures-A Prospective Study on 4 398 Swedish WomenPrevention and treatment of systemic glucocorticoid side effects.Basic and clinical aspects of osteoporosis in inflammatory bowel disease.Ibandronate increases cortical bone density in patients with systemic lupus erythematosus on long-term glucocorticoid.Treatment of bone loss in patients with chronic liver disease awaiting liver transplantationManagement of glucocorticoid-induced osteoporosis: prevalence, and emerging treatment options.Dose-Effectiveness Relationships Determining the Efficacy of Ibandronate for Management of Osteoporosis: A Meta-Analysis.Ibandronate: a clinical pharmacological and pharmacokinetic update.Predictors of Ibandronate Efficacy for the Management of Osteoporosis: A Meta-Regression Analysis.Ibandronate: its pharmacology and clinical efficacy in the management of tumor-induced hypercalcemia and metastatic bone disease.Glucocorticoid-induced osteoporosis: treatment update and review.Discovery, clinical development, and therapeutic uses of bisphosphonates.Ibandronate and cementless total hip arthroplasty: densitometric measurement of periprosthetic bone mass and new therapeutic approach to the prevention of aseptic loosening.How can osteoporosis patients benefit more from their therapy? Adherence issues with bisphosphonate therapy.Prevention and treatment of osteoporosis in inflammatory bowel disease.Quarterly intravenous injection of ibandronate to treat osteoporosis in postmenopausal womenManagement of osteoporosis in the aging male: focus on zoledronic acid.Choosing a treatment for patients at the time a fracture is presented.Management of glucocorticoid-induced osteoporosis.Osteoporosis treatment: why ibandronic acid?Review of new guidelines for the management of glucocorticoid induced osteoporosis.Bisphosphonates in the treatment of glucocorticoid-induced osteoporosis: pros.Effects of neridronate treatment in elderly women with osteoporosis.Daily or monthly ibandronate prevents or restores deteriorations of bone mass, architecture, biomechanical properties and markers of bone turnover in androgen-deficient aged rats
P2860
Q24644708-8228AA46-FD99-4B23-A671-14ABC265F24BQ30946308-CC1E0EF3-EF7F-4351-A3BD-25A6A6BD4D40Q33730223-20736D46-C3BA-40E7-A7B0-A977D228F160Q33857775-419B1E94-5346-4959-A1AE-CFD9065050A1Q34225188-31A0BF30-F162-4464-9F7F-EB7E5F86BD14Q34346425-C39C91AD-65F0-4571-A972-6CF022896B48Q34570115-23DD802F-449F-4FD3-B285-509A18BCD59AQ35026459-42B47CE5-D60C-4FC7-857D-81C3679B278FQ35858255-B2A03F5C-2AF7-4958-906E-AFECF6F0B0BAQ35866199-CCDEC3C2-D7B0-4ADB-9936-939652464BDDQ35940958-2489B28F-6C69-4B08-AB07-EC565FFAC0E3Q35987738-1E5C7115-74A7-4C4B-B42C-E1D27DC2D8D5Q36059394-23FC4225-065A-4AA6-ACB0-78C4E7D331F4Q36065420-024E6E5A-C30E-4E56-90EF-9F2AEA0E08AEQ36084557-9A95A587-520C-410D-8271-D711FE62DA3BQ36492900-1A804342-C61A-4707-9C88-0FFEC9915F1AQ36569260-A903A23E-E6DA-4215-9A30-9790C13767D0Q37017272-A34EFD3A-2165-4CE6-9B1B-D927C7DEB6E6Q37337113-701FBEA1-1C64-4B88-8D18-06448AD3143EQ37886780-627B5246-03BB-466D-8377-5AA301AA4C15Q38033444-45A5543C-1434-4452-BA47-6A26C28E1B4FQ38104738-345A395E-EEEA-4303-8452-E4CCBCC1E801Q38151513-61FDEA31-D9C2-4E21-9EEC-D6D4C1670A5BQ38343436-8B7E2C35-5A33-48D1-9E7F-04FA6598BE50Q53293822-2E326FC1-5586-4C53-95A1-23FA97FE4FFBQ58139568-3FD416B8-6480-4BDE-8E4F-3001386EAA3B
P2860
Intermittent intravenous ibandronate injections reduce vertebral fracture risk in corticosteroid-induced osteoporosis: results from a long-term comparative study.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年学术文章
@wuu
2003年学术文章
@zh
2003年学术文章
@zh-cn
2003年学术文章
@zh-hans
2003年学术文章
@zh-my
2003年学术文章
@zh-sg
2003年學術文章
@yue
2003年學術文章
@zh-hant
name
Intermittent intravenous iband ...... a long-term comparative study.
@en
Intermittent intravenous iband ...... a long-term comparative study.
@nl
type
label
Intermittent intravenous iband ...... a long-term comparative study.
@en
Intermittent intravenous iband ...... a long-term comparative study.
@nl
prefLabel
Intermittent intravenous iband ...... a long-term comparative study.
@en
Intermittent intravenous iband ...... a long-term comparative study.
@nl
P2093
P1476
Intermittent intravenous iband ...... a long-term comparative study.
@en
P2093
P2888
P304
P356
10.1007/S00198-003-1425-0
P407
P577
2003-08-28T00:00:00Z